Shorter Recovery Time After Critical Illness (Nicotinamide Riboside)
Inflammation · Acute Illness
Enrolment: 57 · Results not recorded
Loading the evidence…
Nutraceutical · Nicotinamide riboside (NAD+ precursor vitamin); no curated ChEMBL mechanism record
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Inflammation · Acute Illness
Enrolment: 57 · Results not recorded
Diabetic Neuropathy Peripheral
Enrolment: 10 · Results not recorded
Cognitive Impairment
Enrolment: 50 · Results not recorded
Safety Issues
Enrolment: 400 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Two-thirds partial hepatectomy (resection of median and left lateral lobes)
Nicotinamide riboside raised hepatic NAD by about 22 per cent before and 42 per cent at 48 h after hepatectomy, increased DNA synthesis, raised mitotic activity by 48 per cent, improved liver mass restoration and accelerated ATP recovery, while nearly abolishing regeneration-associated steatosis. H…
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.